U.S. Department of Health & Human Services

NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Recently Added Within 6 Months Remove constraint Recently Added: Within 6 Months Subjects Humans Remove constraint Subjects: Humans Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later
Number of results to display per page

Search Results

102. Reducing potential overuse of dementia drugs could lead to considerable savings

nlm:nlmuid-101743455-pdf

108. California's ambulatory surgery centers: a black box of care

nlm:nlmuid-101744372-pdf

113. California employer health benefits: workers shoulder more costs

nlm:nlmuid-101744473-pdf

114. Ensuring health plan mergers benefit the community: California regulators and infrastructure investment programs

nlm:nlmuid-101744523-pdf

115. California's uninsured: progress toward universal coverage

nlm:nlmuid-101744527-pdf

116. California emergency departments: use grows as coverage expands

nlm:nlmuid-101744542-pdf

117. Financing community health workers in transitions clinics

nlm:nlmuid-101744620-pdf

118. MAT in community health centers

nlm:nlmuid-101744630-pdf

122. Long-acting reversible contraceptives: a survey of Mississippi health care providers

nlm:nlmuid-101744691-pdf

124. How could the public charge proposed rule affect community health centers?

nlm:nlmuid-101744701-pdf

126. Under pressure: adults with hypertension are spending increasingly more on health care

nlm:nlmuid-101744742-pdf

127. The rising cost of specialty drugs drove spending increases for people with multiple sclerosis

nlm:nlmuid-101744756-pdf

128. Trends in primary care visits

nlm:nlmuid-101744765-pdf

129. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices

nlm:nlmuid-101744770-pdf

131. Aligning services with needs: characterizing the pyramid of complexity tiering for children with chronic and complex conditions

nlm:nlmuid-101744810-pdf

134. Threading the labyrinth: why children in California with special health care needs endure delays in securing the medical equipment and supplies they need

nlm:nlmuid-101744823-pdf

136. Achieving care integration for children with medical complexity: the human-centered design approach to care coordination

nlm:nlmuid-101744833-pdf

139. Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report

nlm:nlmuid-101744949-pdf

140. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

nlm:nlmuid-101744954-pdf

143. Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report

nlm:nlmuid-101744957-pdf

145. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report

nlm:nlmuid-101745013-pdf

146. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report

nlm:nlmuid-101745015-pdf

148. Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report

nlm:nlmuid-101745056-pdf

149. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

nlm:nlmuid-101745061-pdf

150. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

nlm:nlmuid-101745064-pdf